key: cord-0982205-j4yrnaaj
authors: Rethinavel, Harini Sri; Ravichandran, Sowbarnika; Radhakrishnan, Risna Kanjirassery; Kandasamy, Mahesh
title: COVID-19 and Parkinson’s disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia
date: 2021-05-11
journal: J Chem Neuroanat
DOI: 10.1016/j.jchemneu.2021.101965
sha: c99f44827b5e1e8f497f14359250c8d49ba03561
doc_id: 982205
cord_uid: j4yrnaaj

Anosmia, a neuropathogenic condition of loss of smell, has been recognized as a key pathogenic hallmark of the current pandemic SARS-CoV-2 infection responsible for COVID-19. While the anosmia resulting from olfactory bulb (OB) pathology is the prominent clinical characteristic of Parkinson's disease (PD), SARS-CoV-2 infection has been predicted as a potential risk factor for developing Parkinsonism-related symptoms in a significant portion of COVID-19 patients and survivors. SARS-CoV-2 infection appears to alter the dopamine system and induce the loss of dopamine neurons that have been known to be the cause of PD. However, the underlying biological basis of anosmia and the potential link between COVID-19 and PD remains obscure. Ample experimental studies in rodents suggest that the occurrence of neural stem cell (NSC) mediated neurogenesis in the OB and olfactory epithelium (OE) is important for olfaction. However, the reports on neurogenesis in the human OB have been a subject of debate, while considerable experimental evidence strongly supports the incidence of neurogenesis in the human OB in adulthood. To note, various viral infections and neuropathogenic conditions including PD with olfactory dysfunctions have been characterized by impaired neurogenesis in OB and OE. Therefore, this article describes and examines the recent reports on SARS-CoV-2 mediated OB dysfunctions and defects in the dopaminergic system responsible for PD. Further, the article emphasizes that COVID-19 and PD associated anosmia could result from the regenerative failure in the replenishment of the dopaminergic neurons in OB and olfactory receptor-expressing neurons in OE respectively.

The coronavirus disease pandemic continues due to the spread of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection worldwide (Kandasamy, 2020a; Korber et al., 2020; Lai et al., 2020; P et al., 2021; Selvaraj et al., 2021; Zheng, 2020) . The typical symptoms of COVID-19 include anosmia and ageusia along with fever, J o u r n a l P r e -p r o o f dry cough and shortness of breath (Ali and Alharbi, 2020; Huang et al., 2020; Kandasamy, 2020a; Meng et al., 2020) . The angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) expressing ciliated cells of the nasal mucosa are the primary targets of initial SARS-CoV-2 infection (Beghi et al., 2020; Sungnak et al., 2020) . A higher level of viral load is found in the nasal cavity of both symptomatic and asymptomatic SARS-CoV-2 infected individuals Meng et al., 2020; Ra et al., 2021) . SARS-CoV-2 spreads from nasal epithelium to different brain regions through the neural pathway of the olfactory bulb (OB) and induces cytokine storm responsible for neuroinflammation, thereby leading to various neurological deficits (DosSantos et al., 2020; Zhang et al., 2020) . Anosmia, a clinical state of loss of smell, has been ascertained as a key symptom of COVID-19 cases regardless of the diagnostic criteria, sex and age (Aziz et al., 2021; Jain et al., 2020; Spinato et al., 2020) . Anosmia can either occur as the only symptom in COVID-19 subjects or take place along with other clinical signs of COVID-19 (Lechien et al., 2020a; Meng et al., 2020) . While the duration of anosmia may be shorter in most COVID-19 cases, it may also be irreversible in subjects with severe OB dysfunction (Gori et al., 2020; Vavougios, 2020) . At present, the underlying pathogenic basis for anosmia in patients with COVID-19 remains obscure. Several magnetic resonance imaging (MRI) and computerized tomography (CT) based brain imaging reports, and neuro clinical correlates have clearly indicated the dysfunction or atrophy of OB in the subjects with COVID-19 (Chiu et al., 2020; Galougahi et al., 2020; Kandemirli et al., 2021) . Defect in the dopamine (DA) system, OB pathology and loss of smell are the prominent clinical characteristic of Parkinson's disease (PD) (Balestrino and Schapira, 2020; Barresi et al., 2012; Haehner et al., 2011; Kouli et al., 2018) . SARS-CoV-2 infection appears to alter the DA system, induce degeneration of DA neurons and synucleinopathies (Brundin et al., 2020; W.-S. Li et al., 2020; Merello et al., 2021; Sulzer et al., 2020) . Hence, SARS-CoV-2 infection has been predicted as a potential risk factor for developing Parkinsonism-related symptoms in a significant portion of J o u r n a l P r e -p r o o f patients and survivors (Brundin et al., 2020; . However, the underlying biological basis of anosmia and the potential link between COVID-19 and PD remains obscure.

Ample experimental studies in rodents suggest that the occurrence of neural stem cell (NSC) mediated neurogenesis in the OB and olfactory epithelium (OE) is important for the sense of smell (Brann and Firestein, 2014; Lledo and Valley, 2016) , whereas impairment of olfactory neurogenesis due to various pathogenic stimuli including neuroinflammation and oxidative stress is associated with loss of smell (Boesveldt et al., 2017; Lazarini et al., 2014) . Notably, the regulation of neurogenesis in OB is negatively altered during viral infections and various neuropathogenic conditions including PD (Kandasamy et al., 2015; Lazarini et al., 2014; Loseva et al., 2009; May et al., 2012) . Though the occurrence of neurogenesis in the human OB is a controversial subject (Bergmann et al., 2012) , there exists considerable experimental evidence that strongly supports the incidence of ongoing neurogenesis in the human OB during adulthood (Durante et al., 2020; Lazarini et al., 2014; Valley, 2016, 2016; Pignatelli and Belluzzi, 2010; Winner et al., 2006a) . Therefore, this article attempts to survey the recent reports on SARS-CoV-2 mediated dysfunction in the OB and defects in the DAergic system responsible for PD.

Further, this article postulates a hypothesis that anosmia resulting from pathogenic events of COVID-19 and PD could be linked to dysregulation of adult neurogenesis in OB and OE. 7 neurons (ORNs) of the nasal neuroepithelium due to neuroinflammation and spread to other brain regions via OB (Gori et al., 2020; Mahalaxmi et al., 2021) . Hyposmia or anosmia has been reported to be highly prevalent among COVID-19 patients (Meng et al., 2020; Sedaghat et al., 2020; Speth et al., 2020) . A retrospective study by Lechien JR et al. reported the occurrence of 85.6% and 88% of olfactory and gustatory dysfunctions respectively in patients with mild to moderate symptoms of COVID-19 (Lechien et al., 2020b) . A smartphone-app-based COVID-19 like symptom tracker study by Menni C et al. revealed a strong association between the loss of smell in 64.76% of patients who confirmed positive for SARS-CoV-2 infection by real time reverse transcriptionpolymerase chain reaction (RT-PCR) (Menni et al., 2020) . A clinical report from China indicated 5.1% of hospitalized COVID-19 patients experiencing loss of smell (Mao et al., 2020 in COVID-19 patients in East Asia, and the difference appears to be independent of age or disease severity (von . Quantitative meta assessments of the olfactory defects in patients with SARS-CoV-2 infection reported some degree of loss of smell in nearly all COVID-19 patients worldwide (Moein et al., 2020; Mullol et al., 2020) . There exist many reports that describe that OD varies from person to person irrespective of age. A Spanish multicenter crosssectional study by Rojas-Lechuga MJ et al. indicated that 70.1% of the COVID-19 subjects confirmed by RT-PCR with a mean age of 46.5 ranging from 21 years to 89 years reported the occurrence of smell loss (Rojas-Lechuga et al., 2021) . Gori A et al. indicated that COVID-19 causes more severe complications in patients with advanced chronological age due to age-related defects of olfactory neuroepithelium and deterioration of OB homeostasis (Gori et al., 2020) . An Italian multicenter-study by Vaira LA et al. reported 51 .5 % of COVID-19 patients showed J o u r n a l P r e -p r o o f 8 olfactory disorders regardless of the difference in gender and age (Vaira et al., 2020 (Mangal et al., 2021 ). An olfactoryaction meter-based study by Bhattacharjee AS et al. reported a significant reduction in the smell detection abilities of asymptomatic COVID-19 patients compared to normal healthy subjects (Bhattacharjee et al., 2020) .

disease (Doty, 2017; Rebholz et al., 2020) . Unlike other neurological diseases, anosmia resulting from the destruction of OB has been ascertained as the non-motor early clinical feature of PD (Doty, 2017 (Doty, , 2012 . The SARS-CoV-2 infection has been predicted as a potential risk factor for developing Parkinsonism-related symptoms in a significant portion of COVID-19 patients and survivors (Brundin et al., 2020; Sulzer et al., 2020) . SARS-CoV-2 infection appears to induce defects in the DA system and loss of DA neuron which is known as the underlying cause of PD (Brundin et al., 2020; W.-S. Li et al., 2020; Merello et al., 2021; Sulzer et al., 2020; Yavarpour-Bali and Ghasemi-Kasman, 2020) . Moreover, PD patients have been reported to be highly susceptible to SARS-CoV-2 infection, and COVID-19 related pathogenic changes appear to exacerbate PD (Brundin et al., 2020; Sulzer et al., 2020) . However, the underlying biological basis of anosmia and the potential link between COVID-19 and PD remains obscure.

Thus, a reciprocal link between COVID-19 and PD has become a topic of scientific focus.

While ageing and age-related diseases are the major risk factors of COVID-19 infection, recent reports indicated the possibilities for the occurrence of PD upon SARS-CoV-2 infection (Sulzer et al., 2020) . PD is one of the common late-onset neurodegenerative disorders mainly characterized by movement disorders consisting of bradykinesia, tremor, imbalance and rigidity with postural instability (DeMaagd and Philip, 2015; Greenland and Barker, 2018; Kouli et al., 2018; Williams and Litvan, 2013) . The movement disorders in PD arises mainly due to the loss of DAergic neurons in the substantia nigra leading to failure in the nigrostriatal pathway (Alexander, 2004; Sonne et al., 2020) . The dysfunction of the DAergic system and degeneration of DAergic neurons in the OB J o u r n a l P r e -p r o o f contribute to olfactory defects in PD (Alexander, 2004; Paß et al., 2020) . Besides, PD has been characterized by the presence of Lewy bodies and α-Synucleinopathies due to a dysfunctional proteostasis network in the brain (Beyer et al., 2009; Lehtonen et al., 2019) . Several lines of evidence stated that the impairment of the sense of smell in PD could also be due to the presence of Lewy bodies and aggregation of α-Synuclein mediated failure of the DAergic system in OB Rey et al., 2018; Sengoku et al., 2008) . There exists a considerable number of experimental proofs that strongly established the concept that viral infections can trigger Lewy bodies and α-Synucleinopathies in the brain (M Takahashi A59 to the basal ganglia, a key brain structure that controls the movement, and observed an abnormal posture, locomotion difficulties, neuronal loss, and gliosis in the substantia nigra (SN) in affected mice (Fishman et al., 1985) . Notably, recent data indicate the expression of ACE2 and dopa decarboxylase (DDC), the enzymes important for the synthesis of DA in the non-neuronal cells (Nataf, 2020) . SARS-CoV infection has been reported to downregulate the expression of ACE2 that could in part play a role in the defect in DA production (Khalefah and Khalifah, 2020; Kuba et al., 2005; Verdecchia et al., 2020) . Moreover, SARS-CoV-2 infection appears to induce in odour detection and discrimination (Wilson and Sullivan, 1995) . In OB, DAergic neurons are replenished by the stem cell-derived ongoing adult neurogenesis (Morrison, 2016) . Considering the fact, it can be expected that the impairment in neuronal replacement of DAergic neurons in OB J o u r n a l P r e -p r o o f may be responsible for the loss of smell in PD and COVID-19. Therefore, the dysregulation of the synthesis of DA, degeneration of DAergic neurons and impaired NSC based regenerative potential in the olfactory system resulting from SARS-CoV-2 infection may collectively contribute to the risk of developing the sporadic form of PD in COVID-19 patients and survivors.

The olfactory system plays an important role in communicating the chemosensory input to the brain (Pinto, 2011; Sharma et al., 2019) . In vertebrates, the olfactory system is divided into the main olfactory system (MOS) and the accessory olfactory system (AOS) (Taniguchi et al., 2011) . In addition, OE contains supporting cell populations like microvillar cells, sustentacular cells, and bowman's gland lining cells (Choi and Goldstein, 2018; Purves et al., 2001; Schwob et al., 2017) .

The GBCs are mitotically active cells that give rise to sustentacular cells and sensory neurons in OE (Carter et al., 2004; Goldstein and Schwob, 1996; Leung et al., 2007) . While HBCs generally remain quiescent in the physiological state, they get activated upon injury and microbial infection (Carter et al., 2004; Iwai et al., 2008; Joiner et al., 2015) . In the nasal cavity, the olfactory receptor (OR) genes are expressed mainly in the sensory neurons of OE (Dang et al., 2018; Mombaerts, 2004; Niimura and Nei, 2006) . ORs belong to G Protein-Coupled Receptor (GPCR) superfamily J o u r n a l P r e -p r o o f and are classified into two different groups, namely class I and class II, based on the phylogenetic difference in mammals (Fleischer et al., 2009; Spehr and Munger, 2009) . Class I receptors mediates the signaling of water-soluble odorants whereas class II receptors are responsible for the perception of aerial odorants (Mezler et al., 2001; Spehr and Munger, 2009) . In mammals, the majority of ORs are classified as class II receptors, and class I receptors are expressed to a lesser extent (Bozza et al., 2009; Ferrer et al., 2016) . The odorant molecule dissolves in the mucus layer of OE and activates the ORNs (Izquierdo-Dominguez et al., 2020; Nagashima and Touhara, 2010) .

The bipolar ORNs extend axons through the cribriform plate and make the synaptic connection with the dendrites of neurons in the glomeruli of OB (Beites et al., 2009; Choi and Goldstein, 2018) . In addition to OE, the other two regions of MOS include the Grüneberg ganglion (GG) and the septal organ (SO) which send projections to OB (Suárez et al., 2012) . In turn, OB transfers the information to other brain regions through the olfactory cortex (Gire et al., 2013; Shepherd, 2010) .

OB is a distinct projected tissue structure present in the forebrain of vertebrates that receive axonal input from OR expressing chemosensory neurons of OE and transfer the information to other brain regions including the cortex, amygdala, hypothalamus and hippocampus (Gire et al., 2013; Miyasaka et al., 2009; Price et al., 1991) . In rodents and other mammals, OB is larger and located at the anterior of the brain (McGann, 2017) . In humans and primates, OB is relatively small and located below the frontal lobe of the brain (McGann, 2017; Semendeferi et al., 1997) . OB consists of multiple layers that include the olfactory nerve layer (ONL), glomerular layer (GML), external plexiform layer (EPL), mitral cell layer (MCL), internal plexiform layer (IPL) and granule cell layer (GCL) (Nagayama et al., 2014) . The synaptic organization in different layers of OB is evident in the mouse model, whereas in humans it has a comparable organization, however with less segregation of cells and lacks the circumferential organization of layers and medial-lateral J o u r n a l P r e -p r o o f symmetry (Maresh et al., 2008) . There are two types of neurons that project via the olfactory tract to higher areas of cortical centers, namely mitral cells located in MCL and tufted cells in EPL (Harvey and Heinbockel, 2018; Nagayama et al., 2014) . The axons of ORNs synapse with the dendrites of mitral and tufted cells in OB (Kim et al., 2020; Nezlin et al., 2003; Vassar et al., 1994) .

The mitral cells project their axons from OB to other regions of the brain (Igarashi et al., 2012; Nagayama et al., 2010) . The OB also contains DAergic neurons in the GML and periglomerular area which plays a prominent role in the detection, discrimination as well as modulation of odour (Paß et al., 2020; Pignatelli and Belluzzi, 2017) . DAergic neurons appear to modulate the activity of both olfactory sensory fibers, mitral and tufted cells in association with granule neurons of GCL (Berkowicz and Trombley, 2000; Cave and Baker, 2009; Pignatelli and Belluzzi, 2017) . Notably, In most vertebrates, neurogenesis in the olfactory system is crucial for daily life activities including food-seeking, pathfinding, social interactions and sexual behaviours (Feierstein, 2012) . In OE, locally residing NSCs and progenitor cells such as HBCs and GBCs represents the cellular regenerative resource for the continual generation of new ORNs throughout adulthood (Brann and Firestein, 2014) . Besides, rodent studies have established the view on adult neurogenesis in the forebrain that NSCs from the subventricular zone (SVZ) differentiate to immature neurons called neuroblasts and migrate through the rostral migratory stream (RMS) to OB where they differentiate and functionally integrate as GABA (Gamma aminobutyric acid) ergic and DAergic interneurons (Kandasamy et al., 2015; Ming and Song, 2011; Winner et al., 2006a) . In addition, the occurrence of adult neurogenesis in OB responsible for olfaction has been reported in many other mammalian species including primates (Kornack and Rakic, 2001) . Unlike in rodents, an extra migratory stream containing immature neurons towards the ventromedial prefrontal cortex has been reported in forebrains of human infants (Sanai et al., 2011) Considering the fact, local progenitor cells residing in the human olfactory system has been speculated to be responsible for adult neurogenesis in OB (Pagano et al., 2000) . However, the occurrence of adult neurogenesis in the forebrain of humans has been a controversial subject (Berger et al., 2020; Sanai et al., 2011) .

There exists supportive evidence that the neurogenesis in the SVZ takes place in adult human brains but it is less active than that in the brains of adult rodents (Parolisi et al., 2018) . The rate of turnover of new neurons in the human brain appears to be slow (Bergmann et al., 2012; Spalding et al., 2013) . A previous carbon dating analysis of the neuronal DNA indicated that the occurrence of neurogenesis is highly limited in adult human OB (Ernst and Frisén, 2015; McGann, 2017) .

However, subsequent studies revealed strong evidence for the existence of ongoing neurogenesis in the human olfactory system in adulthood (Brann and Firestein, 2014; Curtis et al., 2012; Liu and Martin, 2003; Whitman and Greer, 2009) Song et al., 2016; Whitman and Greer, 2009) . Moreover, neurospheres derived from human olfactory mucosa biopsies appeared to be self-renewing and differentiated into neurons and glial cells (Murrell et al., 2005) . Taken together, the presence of NSCs and the occurrence of neurogenesis in the olfactory system of the human brain are increasingly evident.

The ongoing adult neurogenesis in the olfactory system has been linked to the maintenance and rewiring of the neural circuit that is lost due to the ageing and pathogenic process (Pignatelli and Belluzzi, 2010) . Notably, adult neurogenesis in OB appears to be important for odour-based learning, odour discrimination, and mating behaviours (Lledo and Valley, 2016; Pignatelli and Belluzzi, 2010) . Moreover, a number of neurodegenerative diseases including PD have been characterized by impaired neurogenesis in the human OB accountable for deficits in olfactory neuroplasticity, leading to anosmia (Höglinger et al., 2004; Marxreiter et al., 2013; Winner et al., 2006a; Winner and Winkler, 2015) . Besides, many viruses including rhinovirus, Epstein bar virus, and coronaviruses are known to induce dysfunction of OB due to inflammation (Bonzano et al., 2020; Lechien et al., 2020b; Suzuki et al., 2007; van Riel et al., 2015) . While neuroinflammation has been known to impair adult neurogenesis (Fan and Pang, 2017; Kandasamy et al., 2020 Kandasamy et al., , 2015 Kandasamy et al., , 2011 Kandasamy et al., , 2010 , the possibilities of SARS-CoV-2 infection-mediated defect in neurogenesis responsible for anosmia in the olfactory system may not be excluded.

In general, upper respiratory tract infection has been known to be associated with OB dysfunction (Welge-Lüssen and Wolfensberger, 2006) . However, the occurrence of anosmia J o u r n a l P r e -p r o o f resulting from OB dysfunction has been reported in the majority of COVID-19 cases even in aged patients even before the onset of respiratory dysfunctions (Whitcroft and Hummel, 2020) . Thus, WHO has recognized anosmia as a distinct early symptom of SARS-CoV-2 infection. Similarly, anosmia has been well recognized as a pre-clinical symptom of PD (Fullard et al., 2017) . To note, the sensory neurons that express the odorant receptors responsible for the sense of smell are continuously replenished throughout life unlike the other nerve cells in mammalian brains (Brann and Firestein, 2014) . In the olfactory system, these sensory neurons of OE project excitatory synapses with inhibitory interneurons in the granule cell layer of OB through the generation of axonal binding in the glomerular cell layer (Imamura et al., 2020; Lledo et al., 2008) . Notably, ORNs in OE are known to be positive for the markers of immature neurons such as DCX during their generation in adulthood (Saaltink et al., 2012) . While the inhibitory interneurons play a major role in the synaptic input of sensory neurons (Arnson and Strowbridge, 2017; Lledo et al., 2004) , adult neurogenesis contributes to the generation of GABAergic inhibitory interneurons in the GCL of OB (Lledo and Valley, 2016; Pallotto and Deprez, 2014) . Moreover, the axonal processing of sensory neurons in glomeruli appears to be important for the olfactory discrimination (Malnic et al., 2010) , in which, continual generation of DAergic neurons from neural progenitors appears to be highly important (Kandasamy et al., 2015; Lazarini et al., 2014; Pignatelli et al., 2009 ) Thus, the regulation of olfactory neurogenesis provides a cellular mechanism for the sense of smell in physiological conditions (Gheusi and Lledo, 2014) .

To note, reduction of DA in the adult brain appears to alter the number of mitotic cells in the forebrain of PD patients and the animal models of PD (Höglinger et al., 2004; Winner et al., 2006b) (Ziabreva et al., 2007) . Moreover, many experimental models of PD have been characterized by impaired neurogenesis in OB (May et al., 2012; Winner and Winkler, 2015) .

Notably, neuroinflammation appears to impair adult neurogenesis in various neurodegenerative conditions including PD (Kandasamy et al., 2020 (Kandasamy et al., , 2011 Taupin, 2008) . While reduction of DA synthesis has been known to cause the reduction in the proliferation of neural stem cells and progenitors, blockade of neuroinflammation appears to enhance adult neurogenesis, thereby compensating the replenishment of the DAergic neurons in OB and restores olfactory sensory processing in the PD (Lazarini et al., 2014) .

Previously, the extent of epithelial destruction and load of SARS-CoV-2 in OB has been correlated to the varying severity of OD responsible for anosmia (Akerlund et al., 1995; Imam et al., 2020; Yamagishi et al., 1988) . Recently, it has been speculated that the loss of smell noticed in COVID-19 arises because of defects in the supporting cells of OE and vascular pericytes of OB, that could induce a change in the function of ORNs (Butowt and von Solomon, 2021; Vaira et al., 2020) . A case study testified that obstruction in the olfactory cleft caused by inflammation may be a possible reason for anosmia in COVID-19 (Eliezer et al., 2020) , while RNA sequencing and immunostaining studies revealed that ORNs and OE are positive for ACE2 and TMPRSS2 (Bilinska et al., 2020; Brann et al., 2020) . However, Naeini AS et al. did not find any significant mucosal changes or olfactory cleft abnormality in the CT imaging in patients with anosmia of COVID-19 and thus highlighted further experiments are required to elucidate the aetiology of olfactory loss in COVID-19 (Naeini et al., 2020) . Gane SB et al.

hypothesized that anosmia in COVID-19 patients could occur due to the destruction of the ORNs in OE (Gane et al., 2020) . The whole RNA sequencing data of olfactory mucosa in humans showed that the expression of SARS-CoV-2 entry related genes are prominent in most neuronal cells of the olfactory system including the stem cells and progenitors (Brann et al., 2020) . Considering the aforementioned facts, the regenerative aspect of the human olfactory system responsible for the production of new neurons that involves the sense of smell needs to be revisited in COVID-19 conditions. Notably, many neurological deficits noticed in COVID-19 have been related to neuroinflammation due to the prominent cytokine storm . Notably, neuroinflammation has been noticed as a key determinant of the defect in the DAergic system in SN and OB responsible for anosmia in PD (Höglinger et al., 2004; Taupin, 2008) . The proliferative and differentiation potentials of NSCs are known to be drastically impaired by neuroinflammation in PD. Therefore, it can be hypothesized that the pathogenesis of COVID-19 associated neuroinflammation could be an underlying defect in the DAergic system responsible for the development of sporadic PD. Eventually, the pathogenic events of PD and COVID-19 might be in part overlapped at the level of the defect in NSC-mediated neurogenesis in OB and OE leading to anosmia.

The human OE is highly sensitive to environmental changes such as sensory deprivation and inflammation. The OB plays an intermediate role between the OE and higher brain areas in processing the odour information. Regulation of NSC-mediated neurogenesis in OB and OE is important for olfaction. While regulation of neurogenesis in OB and OE is negatively influenced by neuroinflammation, olfactory impairments resulting from neuroinflammation provide a pathogenic interlink between COVID-19 and PD. Considering the fact, SARS CoV-2 infection in Barresi, M., Ciurleo, R., Giacoppo, S., Foti Cuzzola, V., Celi, D., Bramanti, P., Marino, S., 2012 J o u r n a l P r e -p r o o f

Olfactory threshold and nasal mucosal changes in experimentally induced common cold

Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder

COVID-19: Disease, management, treatment, and social impact

Spatial Structure of Synchronized Inhibition in the Olfactory Bulb

The Association of "Loss of Smell" to COVID-19: A Systematic Review and Meta-Analysis

Parkinson disease

Dopaminergic modulation at the olfactory nerve synapse

Molecular Pathology of Lewy Body Diseases

Quantitative assessment of olfactory dysfunction accurately detects asymptomatic COVID-19 carriers

Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age

Doxycycline: From Ocular Rosacea to COVID-19 Anosmia

Mapping of Class I and Class II Odorant Receptors to Glomerular Domains by Two Distinct Types of Olfactory Sensory Neurons in the Mouse

COVID-19-Related Anosmia: The Olfactory Pathway Hypothesis and Early Intervention

Parkinson's Disease: Pathogenesis and Clinical Aspects

Olfactory Loss in Parkinson's Disease

Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson's Disease

Neuromodulation of Synaptic Transmission in the Main Olfactory Bulb

Olfaction in neurodegenerative disorder

Dopamine depletion impairs precursor cell proliferation in Parkinson disease

The generation, migration, and differentiation of olfactory neurons in the adult primate brain

Parkinson's Disease: Etiology, Neuropathology, and Pathogenesis

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Adult neurogenesis restores dopaminergic neuronal loss in the olfactory bulb

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

Dysfunction of Cellular Proteostasis in Parkinson's Disease

Contribution of olfactory neural stem cells to tissue maintenance and regeneration

Olfactory Dysfunction in Recovered Coronavirus Disease 2019 (COVID-19) Patients

Parkinson's disease following COVID-19: causal link or chance occurrence?

Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications

Origin and function of olfactory bulb interneuron diversity

Inhibitory interneurons in the olfactory bulb: from development to function

Adult Olfactory Bulb Neurogenesis

Neurogliogenesis in the mature olfactory system: A possible protective role against infection and toxic dust

Functional genomics suggest neurogenesis in the adult human olfactory bulb

Olfactory and Gustatory Dysfunction in Coronavirus Disease 2019 (COVID-19)

The Neurobiology of Olfaction, Frontiers in Neuroscience

Olfactory Dysfunction Among Asymptomatic Patients with SARS CoV2 Infection: A Case-Control Study

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease

Principles of Glomerular Organization in the Human Olfactory Bulb -Implications for Odor Processing

How COVID-19 can damage the brain

Adult neurogenesis in Parkinson's disease

Poor Human Olfaction is a Nineteenth Century Myth

Acute hypokineticrigid syndrome following SARS-CoV-2 infection

COVID-19 and anosmia: A review based on up-todate knowledge

Real-time tracking of self

SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy

Characteristic features and ligand specificity of the two olfactory receptor classes from Xenopus laevis

Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions

From the Olfactory Bulb to Higher Brain Centers: Genetic Visualization of Secondary

Smell dysfunction: a biomarker for COVID-19

Odorant receptor gene choice in olfactory sensory neurons: the one receptorone neuron hypothesis revisited

Discovery of nigral dopaminergic neurogenesis in adult mice

The rodent accessory olfactory system

The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries

Multipotent stem cells from adult olfactory mucosa

Paranasal sinuses computed tomography findings in anosmia of COVID-19

Enzymatic Conversion of Odorants in Nasal Mucus Affects Olfactory Glomerular Activation Patterns and Odor Perception

Differential Axonal Projection of Mitral and Tufted Cells in the Mouse Main Olfactory System

Neuronal organization of olfactory bulb circuits

An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19

Organization of glomeruli in the main olfactory bulb of Xenopus laevis tadpoles

Evolutionary dynamics of olfactory and other chemosensory receptor genes in vertebrates

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

The effect of drug treatment on neurogenesis in Parkinson's disease

Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-β signalling in COVID-19 survivors

Humans and Dolphins: Decline and Fall of Adult Neurogenesis

The Impact of Mitochondrial Dysfunction on Dopaminergic Neurons in the Olfactory Bulb and Odor Detection

COVID-19 and selective vulnerability to Parkinson's disease

A potential reservoir of immature dopaminergic replacement neurons in the adult mammalian olfactory bulb

Dopaminergic Neurones in the Main Olfactory Bulb: An Overview from an Electrophysiological Perspective

The Neurobiology of Olfaction, Frontiers in Neuroscience

Olfactory projections to the hypothalamus

The Olfactory Epithelium and Olfactory Receptor Neurons

Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection

Loss of Olfactory Function-Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders

The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases

Chemosensory dysfunction in COVID-19 out-patients

Doublecortin and doublecortin-like are expressed in overlapping and non-overlapping neuronal cell population: implications for neurogenesis

Stem and Progenitor Cells of the Mammalian Olfactory Epithelium: Taking Poietic License

Olfactory Dysfunction: A Highly Prevalent Symptom of COVID-19 With Public Health Significance

Testicular Atrophy and Hypothalamic Pathology in COVID-19: Possibility of the Incidence of Male Infertility and HPG Axis Abnormalities

The evolution of the frontal lobes: a volumetric analysis based on three-dimensional reconstructions of magnetic resonance scans of human and ape brains

Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb

Sense of Smell: Structural, Functional, Mechanistic Advancements and Challenges in Human Olfactory Research

New Perspectives on Olfactory Processing and Human Smell

Neurological infection with SARS-CoV-2 -the story so far

Neuronal Circuitry Mechanisms Regulating Adult Mammalian Neurogenesis

Dynamics of hippocampal neurogenesis in adult humans

Olfactory receptors: GPCRs and beyond

Mood, Anxiety and Olfactory Dysfunction in COVID-19: Evidence of Central Nervous System Involvement?

Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection

Mutual influences between the main olfactory and vomeronasal systems in development and evolution

COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside

HCA Lung Biological Network, 2020. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Identification of viruses in patients with postviral olfactory dysfunction

Phylogenic outline of the olfactory system in vertebrates

Adult neurogenesis, neuroinflammation and therapeutic potential of adult neural stem cells

Clinical features of 95 sequential hospitalised patients with

Potential pathogenesis of ageusia and anosmia in COVID-19 patients

The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system: The olfactory nerve: a shortcut for viruses into the CNS

Olfaction and Pheromones: Uncanonical Sensory Influences and Bulbar Interactions

Topographic organization of sensory projections to the olfactory bulb

Potentially irreversible olfactory and gustatory impairments in COVID-19: Indolent vs. fulminant SARS-CoV-2 neuroinfection

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences

Olfactory disorders following upper respiratory tract infections

Olfactory Dysfunction in COVID-19: Diagnosis and Management

Adult Neurogenesis and the Olfactory System

Parkinsonian Syndromes

The D2 antagonist spiperone mimics the effects of olfactory deprivation on mitral/tufted cell odor response patterns

Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb

Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb

Adult neurogenesis in neurodegenerative diseases

Examination and classification of human olfactory mucosa in patients with clinical olfactory disturbances

Update on neurological manifestations of COVID-19

SARS-CoV-2 infects human neural progenitor cells and brain organoids

SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat

Loss of Musashi1 in Lewy body dementia associated with cholinergic deficit